nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—JUN—Irbesartan—type 2 diabetes mellitus	0.261	0.668	CbGbCtD
Arsenic trioxide—AKT1—type 2 diabetes mellitus	0.229	0.594	CbGaD
Arsenic trioxide—ABCC2—type 2 diabetes mellitus	0.109	0.282	CbGaD
Arsenic trioxide—CYP3A4—type 2 diabetes mellitus	0.0481	0.125	CbGaD
Arsenic trioxide—ABCC2—Glyburide—type 2 diabetes mellitus	0.0153	0.0392	CbGbCtD
Arsenic trioxide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0152	0.0388	CbGbCtD
Arsenic trioxide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0135	0.0346	CbGbCtD
Arsenic trioxide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00977	0.025	CbGbCtD
Arsenic trioxide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00908	0.0232	CbGbCtD
Arsenic trioxide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0081	0.0207	CbGbCtD
Arsenic trioxide—AKT1—middle cerebral artery—type 2 diabetes mellitus	0.00763	0.106	CbGeAlD
Arsenic trioxide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00741	0.0189	CbGbCtD
Arsenic trioxide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00671	0.0172	CbGbCtD
Arsenic trioxide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00647	0.0166	CbGbCtD
Arsenic trioxide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00585	0.015	CbGbCtD
Arsenic trioxide—ABCB1—Glyburide—type 2 diabetes mellitus	0.005	0.0128	CbGbCtD
Arsenic trioxide—ABCB1—Losartan—type 2 diabetes mellitus	0.00457	0.0117	CbGbCtD
Arsenic trioxide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00444	0.0113	CbGbCtD
Arsenic trioxide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00425	0.0109	CbGbCtD
Arsenic trioxide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00425	0.0109	CbGbCtD
Arsenic trioxide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00402	0.0103	CbGbCtD
Arsenic trioxide—AKT1—brown adipose tissue—type 2 diabetes mellitus	0.00371	0.0515	CbGeAlD
Arsenic trioxide—AKT1—penis—type 2 diabetes mellitus	0.00353	0.049	CbGeAlD
Arsenic trioxide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.003	0.00766	CbGbCtD
Arsenic trioxide—AKT1—leg—type 2 diabetes mellitus	0.00298	0.0415	CbGeAlD
Arsenic trioxide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00274	0.00701	CbGbCtD
Arsenic trioxide—AKT1—hindlimb—type 2 diabetes mellitus	0.00266	0.037	CbGeAlD
Arsenic trioxide—JUN—peripheral nervous system—type 2 diabetes mellitus	0.00181	0.0251	CbGeAlD
Arsenic trioxide—MAPK3—artery—type 2 diabetes mellitus	0.00173	0.0241	CbGeAlD
Arsenic trioxide—AKT1—artery—type 2 diabetes mellitus	0.00163	0.0227	CbGeAlD
Arsenic trioxide—AKT1—nerve—type 2 diabetes mellitus	0.00162	0.0225	CbGeAlD
Arsenic trioxide—MAPK3—endothelium—type 2 diabetes mellitus	0.00146	0.0203	CbGeAlD
Arsenic trioxide—JUN—artery—type 2 diabetes mellitus	0.00142	0.0198	CbGeAlD
Arsenic trioxide—JUN—nerve—type 2 diabetes mellitus	0.00141	0.0196	CbGeAlD
Arsenic trioxide—AKT1—endothelium—type 2 diabetes mellitus	0.00138	0.0192	CbGeAlD
Arsenic trioxide—TXNRD1—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00136	0.632	CbGdCrCtD
Arsenic trioxide—JUN—endothelium—type 2 diabetes mellitus	0.0012	0.0167	CbGeAlD
Arsenic trioxide—CCND1—islet of Langerhans—type 2 diabetes mellitus	0.00112	0.0155	CbGeAlD
Arsenic trioxide—CCND1—retina—type 2 diabetes mellitus	0.000953	0.0133	CbGeAlD
Arsenic trioxide—MAPK1—islet of Langerhans—type 2 diabetes mellitus	0.00094	0.0131	CbGeAlD
Arsenic trioxide—CCND1—nephron tubule—type 2 diabetes mellitus	0.000898	0.0125	CbGeAlD
Arsenic trioxide—TXNRD1—islet of Langerhans—type 2 diabetes mellitus	0.000875	0.0122	CbGeAlD
Arsenic trioxide—CCND1—cardiovascular system—type 2 diabetes mellitus	0.000806	0.0112	CbGeAlD
Arsenic trioxide—CCND1—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00079	0.368	CbGdCrCtD
Arsenic trioxide—CCND1—kidney—type 2 diabetes mellitus	0.000789	0.011	CbGeAlD
Arsenic trioxide—AKT1—islet of Langerhans—type 2 diabetes mellitus	0.000784	0.0109	CbGeAlD
Arsenic trioxide—CCND1—pancreas—type 2 diabetes mellitus	0.000784	0.0109	CbGeAlD
Arsenic trioxide—CCND1—cortex of kidney—type 2 diabetes mellitus	0.000768	0.0107	CbGeAlD
Arsenic trioxide—MAPK1—nephron tubule—type 2 diabetes mellitus	0.000757	0.0105	CbGeAlD
Arsenic trioxide—TXNRD1—retina—type 2 diabetes mellitus	0.000748	0.0104	CbGeAlD
Arsenic trioxide—CCND1—adipose tissue—type 2 diabetes mellitus	0.000711	0.00989	CbGeAlD
Arsenic trioxide—MAPK3—retina—type 2 diabetes mellitus	0.000711	0.00989	CbGeAlD
Arsenic trioxide—TXNRD1—nephron tubule—type 2 diabetes mellitus	0.000704	0.00979	CbGeAlD
Arsenic trioxide—JUN—islet of Langerhans—type 2 diabetes mellitus	0.000683	0.00949	CbGeAlD
Arsenic trioxide—MAPK1—cardiovascular system—type 2 diabetes mellitus	0.00068	0.00945	CbGeAlD
Arsenic trioxide—AKT1—retina—type 2 diabetes mellitus	0.00067	0.00932	CbGeAlD
Arsenic trioxide—MAPK3—nephron tubule—type 2 diabetes mellitus	0.00067	0.00931	CbGeAlD
Arsenic trioxide—MAPK1—kidney—type 2 diabetes mellitus	0.000665	0.00924	CbGeAlD
Arsenic trioxide—MAPK1—pancreas—type 2 diabetes mellitus	0.00066	0.00918	CbGeAlD
Arsenic trioxide—MAPK1—cortex of kidney—type 2 diabetes mellitus	0.000648	0.009	CbGeAlD
Arsenic trioxide—TXNRD1—cardiovascular system—type 2 diabetes mellitus	0.000632	0.00879	CbGeAlD
Arsenic trioxide—TXNRD1—kidney—type 2 diabetes mellitus	0.000619	0.0086	CbGeAlD
Arsenic trioxide—TXNRD1—pancreas—type 2 diabetes mellitus	0.000615	0.00855	CbGeAlD
Arsenic trioxide—TXNRD1—cortex of kidney—type 2 diabetes mellitus	0.000603	0.00838	CbGeAlD
Arsenic trioxide—MAPK3—cardiovascular system—type 2 diabetes mellitus	0.000601	0.00836	CbGeAlD
Arsenic trioxide—MAPK1—adipose tissue—type 2 diabetes mellitus	0.000599	0.00833	CbGeAlD
Arsenic trioxide—MAPK3—kidney—type 2 diabetes mellitus	0.000588	0.00818	CbGeAlD
Arsenic trioxide—MAPK3—pancreas—type 2 diabetes mellitus	0.000585	0.00813	CbGeAlD
Arsenic trioxide—JUN—retina—type 2 diabetes mellitus	0.000584	0.00811	CbGeAlD
Arsenic trioxide—MAPK3—cortex of kidney—type 2 diabetes mellitus	0.000573	0.00797	CbGeAlD
Arsenic trioxide—AKT1—cardiovascular system—type 2 diabetes mellitus	0.000567	0.00789	CbGeAlD
Arsenic trioxide—TXNRD1—adipose tissue—type 2 diabetes mellitus	0.000558	0.00776	CbGeAlD
Arsenic trioxide—AKT1—kidney—type 2 diabetes mellitus	0.000555	0.00772	CbGeAlD
Arsenic trioxide—AKT1—pancreas—type 2 diabetes mellitus	0.000551	0.00767	CbGeAlD
Arsenic trioxide—JUN—nephron tubule—type 2 diabetes mellitus	0.00055	0.00764	CbGeAlD
Arsenic trioxide—AKT1—cortex of kidney—type 2 diabetes mellitus	0.00054	0.00751	CbGeAlD
Arsenic trioxide—MAPK3—adipose tissue—type 2 diabetes mellitus	0.00053	0.00737	CbGeAlD
Arsenic trioxide—AKT1—adipose tissue—type 2 diabetes mellitus	0.0005	0.00695	CbGeAlD
Arsenic trioxide—CCND1—liver—type 2 diabetes mellitus	0.000499	0.00693	CbGeAlD
Arsenic trioxide—JUN—cardiovascular system—type 2 diabetes mellitus	0.000494	0.00686	CbGeAlD
Arsenic trioxide—IKBKB—cardiovascular system—type 2 diabetes mellitus	0.000491	0.00683	CbGeAlD
Arsenic trioxide—JUN—kidney—type 2 diabetes mellitus	0.000483	0.00672	CbGeAlD
Arsenic trioxide—JUN—pancreas—type 2 diabetes mellitus	0.00048	0.00667	CbGeAlD
Arsenic trioxide—JUN—cortex of kidney—type 2 diabetes mellitus	0.00047	0.00654	CbGeAlD
Arsenic trioxide—IKBKB—cortex of kidney—type 2 diabetes mellitus	0.000468	0.00651	CbGeAlD
Arsenic trioxide—JUN—adipose tissue—type 2 diabetes mellitus	0.000435	0.00605	CbGeAlD
Arsenic trioxide—IKBKB—adipose tissue—type 2 diabetes mellitus	0.000433	0.00602	CbGeAlD
Arsenic trioxide—MAPK1—liver—type 2 diabetes mellitus	0.00042	0.00584	CbGeAlD
Arsenic trioxide—TXNRD1—liver—type 2 diabetes mellitus	0.000391	0.00544	CbGeAlD
Arsenic trioxide—MAPK3—liver—type 2 diabetes mellitus	0.000372	0.00517	CbGeAlD
Arsenic trioxide—AKT1—liver—type 2 diabetes mellitus	0.000351	0.00488	CbGeAlD
Arsenic trioxide—JUN—liver—type 2 diabetes mellitus	0.000305	0.00424	CbGeAlD
Arsenic trioxide—IKBKB—liver—type 2 diabetes mellitus	0.000304	0.00422	CbGeAlD
Arsenic trioxide—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000299	0.00416	CbGeAlD
Arsenic trioxide—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000293	0.00407	CbGeAlD
Arsenic trioxide—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000263	0.00366	CbGeAlD
Arsenic trioxide—ABCC2—kidney—type 2 diabetes mellitus	0.000263	0.00366	CbGeAlD
Arsenic trioxide—CYP1B1—kidney—type 2 diabetes mellitus	0.000257	0.00358	CbGeAlD
Arsenic trioxide—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000256	0.00356	CbGeAlD
Arsenic trioxide—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000251	0.00349	CbGeAlD
Arsenic trioxide—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000232	0.00323	CbGeAlD
Arsenic trioxide—CYP1A1—kidney—type 2 diabetes mellitus	0.000182	0.00253	CbGeAlD
Arsenic trioxide—ABCC2—liver—type 2 diabetes mellitus	0.000166	0.00231	CbGeAlD
Arsenic trioxide—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000164	0.00228	CbGeAlD
Arsenic trioxide—CYP1B1—liver—type 2 diabetes mellitus	0.000163	0.00226	CbGeAlD
Arsenic trioxide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000134	0.00186	CbGeAlD
Arsenic trioxide—CYP3A4—kidney—type 2 diabetes mellitus	0.000134	0.00186	CbGeAlD
Arsenic trioxide—CYP1A1—liver—type 2 diabetes mellitus	0.000115	0.0016	CbGeAlD
Arsenic trioxide—ABCB1—retina—type 2 diabetes mellitus	0.000114	0.00159	CbGeAlD
Arsenic trioxide—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000108	0.0015	CbGeAlD
Arsenic trioxide—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.66e-05	0.00134	CbGeAlD
Arsenic trioxide—ABCB1—kidney—type 2 diabetes mellitus	9.45e-05	0.00131	CbGeAlD
Arsenic trioxide—ABCB1—pancreas—type 2 diabetes mellitus	9.39e-05	0.00131	CbGeAlD
Arsenic trioxide—ABCB1—cortex of kidney—type 2 diabetes mellitus	9.21e-05	0.00128	CbGeAlD
Arsenic trioxide—ABCB1—adipose tissue—type 2 diabetes mellitus	8.52e-05	0.00118	CbGeAlD
Arsenic trioxide—CYP3A4—liver—type 2 diabetes mellitus	8.44e-05	0.00117	CbGeAlD
Arsenic trioxide—ABCB1—liver—type 2 diabetes mellitus	5.98e-05	0.000831	CbGeAlD
Arsenic trioxide—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.43e-06	9.6e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—SRC—type 2 diabetes mellitus	1.43e-06	9.6e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—INS—type 2 diabetes mellitus	1.43e-06	9.57e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—INS—type 2 diabetes mellitus	1.42e-06	9.51e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—NFKB1—type 2 diabetes mellitus	1.42e-06	9.51e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—AKT1—type 2 diabetes mellitus	1.41e-06	9.45e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.4e-06	9.42e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.4e-06	9.41e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.39e-06	9.34e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.39e-06	9.32e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—SRC—type 2 diabetes mellitus	1.39e-06	9.31e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—INS—type 2 diabetes mellitus	1.38e-06	9.28e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.38e-06	9.25e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.38e-06	9.25e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.37e-06	9.22e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.37e-06	9.21e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.37e-06	9.18e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PTGS2—type 2 diabetes mellitus	1.37e-06	9.18e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.36e-06	9.16e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.36e-06	9.15e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.36e-06	9.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.36e-06	9.13e-06	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.36e-06	9.1e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—NFKB1—type 2 diabetes mellitus	1.36e-06	9.09e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—AKT1—type 2 diabetes mellitus	1.35e-06	9.04e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.34e-06	8.98e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	1.34e-06	8.98e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.34e-06	8.97e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.34e-06	8.97e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.33e-06	8.94e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.33e-06	8.93e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SRC—type 2 diabetes mellitus	1.32e-06	8.86e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—SRC—type 2 diabetes mellitus	1.32e-06	8.86e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—INS—type 2 diabetes mellitus	1.32e-06	8.83e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	1.32e-06	8.82e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.31e-06	8.82e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.31e-06	8.79e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.31e-06	8.78e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—type 2 diabetes mellitus	1.31e-06	8.76e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.3e-06	8.73e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.3e-06	8.73e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	8.72e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.29e-06	8.69e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.29e-06	8.68e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.29e-06	8.68e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.29e-06	8.68e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.28e-06	8.6e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SRC—type 2 diabetes mellitus	1.28e-06	8.59e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	1.28e-06	8.57e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.27e-06	8.54e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.27e-06	8.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.27e-06	8.52e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.27e-06	8.5e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—SRC—type 2 diabetes mellitus	1.26e-06	8.47e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.26e-06	8.47e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—INS—type 2 diabetes mellitus	1.26e-06	8.45e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—type 2 diabetes mellitus	1.25e-06	8.41e-06	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.25e-06	8.4e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.25e-06	8.39e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.25e-06	8.39e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	8.34e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	8.34e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.24e-06	8.33e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.24e-06	8.32e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.24e-06	8.32e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.24e-06	8.31e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.24e-06	8.3e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.24e-06	8.3e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.24e-06	8.3e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.24e-06	8.3e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	8.22e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	1.22e-06	8.18e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SRC—type 2 diabetes mellitus	1.22e-06	8.18e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.22e-06	8.17e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.22e-06	8.16e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—type 2 diabetes mellitus	1.22e-06	8.16e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.21e-06	8.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.21e-06	8.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.21e-06	8.11e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.19e-06	8.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	1.19e-06	7.98e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.19e-06	7.96e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—type 2 diabetes mellitus	1.18e-06	7.92e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.18e-06	7.9e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	1.16e-06	7.77e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—type 2 diabetes mellitus	1.16e-06	7.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—type 2 diabetes mellitus	1.16e-06	7.76e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.16e-06	7.76e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.15e-06	7.74e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.15e-06	7.74e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—type 2 diabetes mellitus	1.15e-06	7.68e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.14e-06	7.67e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.14e-06	7.66e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-06	7.63e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—type 2 diabetes mellitus	1.12e-06	7.53e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—type 2 diabetes mellitus	1.11e-06	7.43e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	7.41e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.1e-06	7.41e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.1e-06	7.41e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.1e-06	7.4e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.1e-06	7.36e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—type 2 diabetes mellitus	1.09e-06	7.31e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.09e-06	7.29e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.08e-06	7.22e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.07e-06	7.18e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.07e-06	7.18e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—type 2 diabetes mellitus	1.07e-06	7.17e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.06e-06	7.14e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.06e-06	7.12e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.05e-06	7.08e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.05e-06	7.05e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.04e-06	7.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.04e-06	7e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RELA—type 2 diabetes mellitus	1.04e-06	6.97e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.03e-06	6.93e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.03e-06	6.91e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.03e-06	6.91e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.03e-06	6.88e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.02e-06	6.86e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.02e-06	6.86e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.02e-06	6.84e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-06	6.78e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.01e-06	6.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.01e-06	6.77e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1e-06	6.73e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—type 2 diabetes mellitus	1e-06	6.73e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.93e-07	6.66e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	9.92e-07	6.66e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	9.89e-07	6.64e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	9.83e-07	6.6e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	9.83e-07	6.6e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	9.83e-07	6.6e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.8e-07	6.57e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	9.77e-07	6.55e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	9.74e-07	6.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.73e-07	6.53e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.73e-07	6.53e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—type 2 diabetes mellitus	9.64e-07	6.47e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SRC—type 2 diabetes mellitus	9.63e-07	6.46e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.63e-07	6.46e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	9.6e-07	6.44e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	9.53e-07	6.4e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	9.5e-07	6.37e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	9.49e-07	6.36e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.44e-07	6.33e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.38e-07	6.29e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.37e-07	6.29e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—type 2 diabetes mellitus	9.35e-07	6.27e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.26e-07	6.21e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—type 2 diabetes mellitus	9.25e-07	6.21e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	9.25e-07	6.21e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.25e-07	6.21e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.16e-07	6.15e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.14e-07	6.13e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.01e-07	6.04e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.98e-07	6.02e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SRC—type 2 diabetes mellitus	8.97e-07	6.02e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	8.9e-07	5.97e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—type 2 diabetes mellitus	8.9e-07	5.97e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—type 2 diabetes mellitus	8.89e-07	5.97e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.86e-07	5.94e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	8.82e-07	5.92e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	8.82e-07	5.92e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	8.82e-07	5.92e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	8.77e-07	5.88e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.77e-07	5.88e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.74e-07	5.86e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	8.73e-07	5.86e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	8.66e-07	5.81e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—type 2 diabetes mellitus	8.63e-07	5.79e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—type 2 diabetes mellitus	8.62e-07	5.79e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.61e-07	5.77e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	8.6e-07	5.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	8.58e-07	5.75e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—type 2 diabetes mellitus	8.58e-07	5.75e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.54e-07	5.73e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—type 2 diabetes mellitus	8.51e-07	5.71e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.44e-07	5.66e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	8.39e-07	5.63e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	8.33e-07	5.59e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.31e-07	5.58e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.27e-07	5.55e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—type 2 diabetes mellitus	8.21e-07	5.51e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—type 2 diabetes mellitus	8.21e-07	5.5e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	8.19e-07	5.49e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SRC—type 2 diabetes mellitus	8.17e-07	5.48e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	8.16e-07	5.48e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.11e-07	5.44e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	8.07e-07	5.41e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	8.07e-07	5.41e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.02e-07	5.38e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	8e-07	5.37e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.97e-07	5.35e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.97e-07	5.35e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—type 2 diabetes mellitus	7.96e-07	5.34e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.96e-07	5.34e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.86e-07	5.28e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—type 2 diabetes mellitus	7.85e-07	5.27e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.66e-07	5.14e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	7.66e-07	5.14e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	7.65e-07	5.13e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	7.65e-07	5.13e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.63e-07	5.12e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—type 2 diabetes mellitus	7.58e-07	5.08e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.48e-07	5.02e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.3e-07	4.9e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.16e-07	4.8e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	7.11e-07	4.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	7e-07	4.7e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.97e-07	4.68e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.59e-07	4.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	6.59e-07	4.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	6.56e-07	4.4e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—type 2 diabetes mellitus	6.49e-07	4.35e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	6.47e-07	4.34e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	6.39e-07	4.29e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	6.28e-07	4.21e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.23e-07	4.18e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	6.12e-07	4.1e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.12e-07	4.1e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	6.11e-07	4.1e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.04e-07	4.05e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	6e-07	4.02e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.98e-07	4.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.87e-07	3.94e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.85e-07	3.93e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.75e-07	3.86e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	5.71e-07	3.83e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.7e-07	3.82e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	5.63e-07	3.78e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	5.59e-07	3.75e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.58e-07	3.74e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—type 2 diabetes mellitus	5.5e-07	3.69e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	5.4e-07	3.62e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.31e-07	3.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	5.3e-07	3.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.13e-07	3.44e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.08e-07	3.4e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.05e-07	3.39e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.03e-07	3.37e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.97e-07	3.33e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	4.38e-07	2.94e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.3e-07	2.88e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.94e-07	2.64e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.77e-07	2.53e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.77e-07	2.53e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	3.52e-07	2.36e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.45e-07	2.31e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.81e-07	1.89e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.73e-07	1.16e-06	CbGpPWpGaD
